{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:41:54Z","timestamp":1794368514950,"version":"4.9.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005227","name":"Centers for Medicare and Medicaid Services","doi-asserted-by":"publisher","award":["R01DA039192"],"award-info":[{"award-number":["R01DA039192"]}],"id":[{"id":"10.13039\/100005227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ajpm-online.net","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.amepre.2025.01.019","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T16:45:56Z","timestamp":1738255556000},"page":"1015-1021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Use of Medications for Opioid Use Disorder in Older Adults"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1927-0927","authenticated-orcid":false,"given":"Yong-Fang","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1473-1766","authenticated-orcid":false,"given":"Jordan","family":"Westra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edythe P.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7460-7281","authenticated-orcid":false,"given":"Mukaila A.","family":"Raji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amepre.2025.01.019_bib0001","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.amepre.2021.01.010","article-title":"Trends in opioid use disorder among older adults: analyzing Medicare data, 2013-2018","volume":"60","author":"Shoff","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2025.01.019_bib0002","doi-asserted-by":"crossref","unstructured":"Kramarow EA, Tejada-Vera B. (2022). Drug overdose deaths in adults aged 65 and over: United States, 2000-2020. (NCHS Data Brief. No. 455). National Center for Health Statistics. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db455.pdf. Accessed September 11, 2024.","DOI":"10.15620\/cdc:121828"},{"issue":"7","key":"10.1016\/j.amepre.2025.01.019_bib0003","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/j.amjmed.2022.02.039","article-title":"Opioid and benzodiazepine substitutes: impact on drug overdose mortality in Medicare population","volume":"135","author":"Kuo","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.amepre.2025.01.019_bib0004","unstructured":"National Institute on Drug Abuse. 2020. Substance Use in Older Adults DrugFacts. https:\/\/nida.nih.gov\/publications\/drugfacts\/substance-use-in-older-adults-drugfacts. Retrieved on October 24, 2024."},{"issue":"2","key":"10.1016\/j.amepre.2025.01.019_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.amepre.2025.01.019_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14925","article-title":"Estimated reductions in opioid overdose deaths with sustainment of public health interventions in 4 US states","volume":"6","author":"Chhatwal","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.amepre.2025.01.019_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2025.01.019_bib0008","unstructured":"Maxwell A. (2023). The consistently low percentage of Medicare enrollees receiving medication to treat their opioid use disorder remains a concern. (OEI-02-23-00250). U.S. Department of Health and Human Services, Office of the Inspector General. https:\/\/oig.hhs.gov\/documents\/evaluation\/2722\/OEI-02-23-00250-Complete%20Report.pdf. Accessed September 11, 2024."},{"issue":"5","key":"10.1016\/j.amepre.2025.01.019_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14328","article-title":"Trends in methadone dispensing for opioid use disorder after Medicare payment policy changes","volume":"6","author":"Taylor","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.amepre.2025.01.019_bib0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.amjmed.2022.01.032","article-title":"Association of medication-assisted therapy with new onset of cardiac arrhythmia in patients diagnosed with opioid use disorders","volume":"135","author":"Raji","year":"2022","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.amepre.2025.01.019_bib0011","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/15563650.2022.2028802","article-title":"Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study","volume":"60","author":"Baumgartner","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.1016\/j.amepre.2025.01.019_bib0012","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/jpm.2011.0198","article-title":"The effect of age on opioid switching to methadone: a systematic review","volume":"15","author":"Mercadante","year":"2012","journal-title":"J Palliat Med"},{"issue":"2","key":"10.1016\/j.amepre.2025.01.019_bib0013","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/dmd.121.000646","article-title":"The impact of age and genetics on naltrexone biotransformation","volume":"50","author":"Stancil","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.amepre.2025.01.019_bib0014","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s44158-024-00182-2","article-title":"Influence of aging on opioid dosing for perioperative pain management: a focus on pharmacokinetics","volume":"4","author":"Mercadante","year":"2024","journal-title":"J Anesth Analg Crit Care"},{"issue":"9","key":"10.1016\/j.amepre.2025.01.019_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-2004-825883","article-title":"Einsatz der Opioide bei alten Patienten \u2013 Pharmakokinetische und pharmakodynamische Uberlegungen [Use of opioids in the elderly \u2013 pharmacokinetic and pharmacodynamic considerations]","volume":"39","author":"Freye","year":"2004","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"12","key":"10.1016\/j.amepre.2025.01.019_bib0016","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40266-021-00893-z","article-title":"Problematic opioid use among older adults: epidemiology, adverse outcomes and treatment considerations","volume":"38","author":"Dufort","year":"2021","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amepre.2025.01.019_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108282","article-title":"Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries","volume":"124","author":"Kuo","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"10.1016\/j.amepre.2025.01.019_bib0018","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/CLEP.S105613","article-title":"Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US","volume":"9","author":"Mues","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.amepre.2025.01.019_bib0019","unstructured":"Centers for Medicare & Medicaid Services. Chronic conditions data warehouse: chronic conditions. 2024. Accessed Oct 24, 2024. https:\/\/www2.ccwdata.org\/web\/guest\/condition-categories-chronic"},{"key":"10.1016\/j.amepre.2025.01.019_bib0020","article-title":"Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016-2019","volume":"10","author":"Shearer","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"issue":"7","key":"10.1016\/j.amepre.2025.01.019_bib0021","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s11606-021-07130-8","article-title":"Multimorbidity and inpatient utilization among older adults with opioid use disorder in New York City","volume":"37","author":"Han","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2025.01.019_bib0022","doi-asserted-by":"crossref","first-page":"21r03223","DOI":"10.4088\/PCC.21r03223","article-title":"The growing epidemic of opioid use disorder in the elderly and its treatment: a review of the literature","volume":"25","author":"Konakanchi","year":"2023","journal-title":"Prim Care Companion CNS Disord"},{"issue":"9","key":"10.1016\/j.amepre.2025.01.019_bib0023","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/add.13013","article-title":"Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration","volume":"110","author":"Kao","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.amepre.2025.01.019_bib0024","article-title":"Medicaid expansion and medications to treat opioid use disorder in outpatient specialty care from 2010 to 2020","volume":"168","author":"Presskreischer","year":"2024","journal-title":"J Subst Use Addict Treat"},{"key":"10.1016\/j.amepre.2025.01.019_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108849","article-title":"Racial\/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US","volume":"226","author":"Stahler","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.amepre.2025.01.019_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.amepre.2025.01.019_bib0027","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s11606-020-06339-3","article-title":"Validity of incident opioid use disorder (OUD) diagnoses in administrative data: a chart verification study","volume":"36","author":"Howell","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2025.01.019_bib0028","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/add.16338","article-title":"Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: challenges and opportunities","volume":"119","author":"Osterhage","year":"2024","journal-title":"Addiction"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379725000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379725000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T09:59:29Z","timestamp":1745402369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379725000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0749379725000303"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2025.01.019","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Medications for Opioid Use Disorder in Older Adults","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2025.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}